Omnipod warning 2026: Check affected lots and spot under-delivery

A new FDA-posted safety action affects specific lots of Omnipod 5, DASH, and Eros pods. Here’s how to check yours, spot possible insulin under-delivery, and know when high blood sugar may be an emergency.

A newly posted FDA safety action does not mean every Omnipod product needs to be stopped. The May 26, 2026 action applies to specific lots of Omnipod 5, Omnipod DASH, and Omnipod Eros pods that may deliver too little insulin because of a manufacturing problem.

The first practical step is to check the lot number on your pod tray lid, pod box, or the pod itself. If you are currently using a pod from an affected lot, the FDA says to change it right away and use a pod from an unaffected lot so insulin delivery can continue.

What happened

According to the company notice posted by the FDA, Insulet began a voluntary medical device correction after identifying a manufacturing issue that could lead to insulin under-delivery. The problem involves a small tear in the cannula, the tiny tube that sits just under the skin and delivers insulin.

If that tear is present, some insulin can leak out instead of going into the body as intended. That can raise blood sugar and, in severe cases, contribute to diabetic ketoacidosis, or DKA, which is a medical emergency.

The action covers certain lots of three product lines used in the United States: Omnipod 5, Omnipod DASH, and Omnipod Insulin Management System, also called Omnipod Eros. Pods outside the affected lots are not part of this correction. Insulet says it identified the cause, put corrective steps in place, and is offering replacement pods at no cost. In the FDA-posted notice, the company said there had been 24 serious adverse-event reports globally linked to high blood sugar, including hospitalization and DKA, with no deaths reported.

How to check whether your pod is affected

The FDA says users should check the lot number on the tray lid, the box, or the pod itself. All pods in one box come from the same lot, so if that lot is on the affected list, none of the pods in that box should be used.

If your current pod is from an affected lot, the FDA says to discontinue it immediately and change to a pod from an unaffected lot. Insulet has also directed customers to its lot-check and replacement process for unused affected pods.

If you help someone else manage diabetes, including a child, older adult, or person with disabilities, make sure anyone involved in day-to-day care knows how to find the lot number and what the backup plan is if an affected pod is found.

What insulin under-delivery can look like in real life

The warning signs may be easy to miss. The FDA says people using an affected pod may notice wetness on the skin or adhesive, or smell insulin. Blood sugar may start rising and may not respond the way you would expect after insulin delivery.

Some Omnipod 5 users may see an Automated Delivery Restriction alert, but the FDA also warns that this problem may happen without a device alert. In other words, a pod can under-deliver insulin even if the system does not clearly warn you that something is wrong.

The FDA also notes that this issue does not affect continuous glucose monitor systems or CGM readings themselves. The concern is the pod’s insulin delivery, not the glucose sensor.

When high blood sugar becomes an emergency

High blood sugar is not always an emergency, but it can become one if insulin delivery is reduced for too long. The Centers for Disease Control and Prevention says DKA develops when the body does not have enough insulin. It is most common in people with type 1 diabetes, but people with type 2 diabetes can develop it too. Symptoms can include intense thirst, very dry mouth, nausea, vomiting, stomach pain, fast or deep breathing, headache, fruity-smelling breath, and extreme tiredness.

CDC guidance says people with diabetes should check for ketones if they are sick or if blood sugar is 250 mg/dL or higher. Ketones should also be checked if DKA symptoms appear. The American Diabetes Association says blood ketone testing is preferred when available and advises emergency medical care if blood ketones are 1.6 mmol/L or higher.

The CDC says to go to the emergency room or call 911 right away if blood sugar stays at 300 mg/dL or above, if breath smells fruity, if vomiting prevents keeping food or drinks down, if breathing becomes difficult, or if there are multiple signs of DKA. High ketones are also a reason to seek emergency care right away.

What to do if replacements or usable pods are a problem

Insulet says replacement pods are available at no cost, but some people may still run into a short-term problem if they discover affected pods and do not have enough unaffected ones on hand. In that situation, the FDA says to contact your healthcare provider about other methods of insulin delivery.

This is especially important for people who use insulin continuously and cannot safely go without a backup plan. Your diabetes care team can explain the safest next step for your situation while you wait for replacements. If you are unsure what to do, do not guess at a substitute plan on your own.

Do not confuse this with the March 2026 Omnipod 5 recall

This May 26, 2026 action is separate from an earlier Omnipod 5 problem initiated on March 12, 2026. The FDA’s current early alert specifically says the newer issue is separate, and the earlier action has its own FDA Class I recall record.

That distinction matters because people may see headlines or social posts about “the Omnipod recall” and assume everything refers to the same event. It does not. The current warning includes certain lots across Omnipod 5, DASH, and Eros pods. The earlier March action involved certain Omnipod 5 pods and appears in a separate federal recall database entry.

What readers can do now

If you use Omnipod pods, or care for someone who does, reasonable next steps are:

  • Check the lot number on every pod box, tray lid, or pod before use.
  • If a currently used pod is from an affected lot, change it right away to an unaffected pod.
  • Watch for wetness, an insulin smell, rising glucose, or glucose that is not responding as expected.
  • Do not rely only on pod alerts to tell you something is wrong.
  • Keep ketone supplies available if you or your family member is at risk for DKA.
  • Contact Insulet for replacement instructions and contact your diabetes care team if you do not have enough unaffected pods.
  • Seek urgent or emergency care for signs of DKA or high ketones.

What remains uncertain

As of June 4, 2026, the FDA says it is still reviewing this as a potentially high-risk device issue and will update the public as significant new information becomes available. That means details could change as the federal review continues.

For now, the key point is narrower than many people may assume: this is a lot-specific safety problem, not a blanket shutdown of all Omnipod products. But for anyone using an affected pod, it is a problem that needs quick attention because missed insulin can become dangerous fast.

Sources

Editorial note: Weence articles are researched from cited public-health, medical, regulatory, journal, and reputable news sources and may be drafted with AI assistance. They are checked for source support, clarity, and safety guardrails before publication.

This article is for general informational purposes only and is not medical advice. Research findings can be early or incomplete, and health guidance can change. Always talk with a qualified healthcare professional about personal symptoms, diagnosis, medications, vaccines, screenings, or treatment decisions. If you think you may have a medical emergency, call emergency services right away.